AIM

AIM ImmunoTech Inc.

$0.16

Current Price

All

AI analysis

Read what the AI thinks of AIM ImmunoTech Inc. in the app.

Analyses are generated by AI from public data and are not investment advice.

Get the app

Key figures

Dividend per share

—

Yield

—

EPS

-$3.93

P/E

—

Data as of Oct 1

Why it matters for the long term

Over 10-20 years, what drives a share up is the growth of its profits (EPS) + reinvested dividends. The P/E tells you whether you are paying a lot or a little for that growth. In short: rising EPS + reasonable P/E + growing dividend = good long-term candidate.

Upcoming events

Quarterly earnings

Expected EPS: -$0.14

Nov 16

Posts

No posts about AIM yet.

About AIM ImmunoTech Inc.

AIM ImmunoTech is a small biotechnology company that develops drugs meant to boost the immune system and fight viruses and cancer. It has almost no sales, so it pays its bills by raising money from investors rather than by selling products. Its value rests on whether its experimental treatments succeed in trials.